Lilie L. Lin, MD

Peer-Reviewed Articles

1. Kim M, Maldonado JA, Pandey P, El Alam MB, Kouzy R, Christopherson K, Minsky BD, Nugyen QN, Grosshans D, Lin LL, Mitchell MP, Klopp AH, Lee PP, Bird J, Satcher R, Lewis VO, Lin PP, Tang C, Koong AC, Moon B, Colbert LE. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care. e-Pub 2024. PMID: 38843933.
2. Court LE, Aggarwal A, Jhingran A, Naidoo K, Netherton T, Olanrewaju A, Peterson C, Parkes J, Simonds H, Trauernicht C, Zhang L, Beadle BM, Radiation Planning Assistant Consortium. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care. JCO Glob Oncol 10:e2300376, 2024. PMID: 38484191.
3. Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2023. PMID: 37914588.
4. Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180:24-34, 2024. e-Pub 2023. PMID: 38041900.
5. Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. e-Pub 2023. PMID: 38129211.
6. Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. e-Pub 2023. PMID: 37863066.
7. Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial. Pract Radiat Oncol. e-Pub 2023. PMID: 37597615.
8. Simiele SJ, Charyyev S, Lin L, Kim L, Wang D, Gronberg MP, MPLA Cases Subcommittee. MPLA case: I didn't realize those were the expectations!. J Appl Clin Med Phys 24(8):e14089, 2023. e-Pub 2023. PMID: 37415409.
9. Lin LL, Ndlovu N, Lowenstein J, Wirth M, Lee J, Stier EA, Garg M, Kotzen J, Kadzatsa W, Palefsky J, Krown SE, Einstein MH. Quality Assurance in Clinical Trials Requiring Radiotherapy in sub-Saharan Africa. Int J Radiat Oncol Biol Phys 116(2):439-447, 2023. e-Pub 2022. PMID: 36493958.
10. Lin LL, Msadabwe SC, Chiao E. Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer. Int J Radiat Oncol Biol Phys 116(2):459-462, 2023. PMID: 37179093.
11. Pantel AR, Gitto SB, Makvandi M, Kim H, Medvedv S, Weeks JK, Torigian DA, Hsieh CJ, Ferman B, Latif NA, Tanyi JL, Martin LP, Lanzo SM, Liu F, Cao Q, Mills GB, Doot RK, Mankoff DA, Mach RH, Lin LL, Simpkins F. [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a pilot study. Clin Cancer Res 29(8):1515-1527, 2023. e-Pub 2022. PMID: 36441795.
12. Kamrava M, Leung E, Bachand F, Beriwal S, Chargari C, D'Souza D, Erickson B, Fokdal L, Han K, Harkenrider M, Lin L, Mahantshetty U, Nesvacil N, Ravi A, Schmid M, Vigneault E, Westerveld H, Yashar C, Nout R. GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina. Int J Radiat Oncol Biol Phys 115(3):654-663, 2023. e-Pub 2022. PMID: 36191741.
13. Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
14. Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2022. PMID: 36494250.
15. Diao K, Kizub DA, Ausat N, Mwaba CK, Anakwenze Akinfenwa CP, Cameron CA, Chiao EY, Lombe DC, Msadabwe SC, Lin LL. Perspectives of Zambian Clinical Oncology Trainees in the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART). Oncologist 27(10):e804-e810, 2022. e-Pub 2022. PMID: 35689473.
16. Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
17. Woodhouse KD, Devlin PM, Kollmeier M, Lin LL, Orio P, Ouhib Z, Song D, Viswanathan AN, Watanabe Y, Yu Y, Small W, Schechter NR. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. Am J Clin Oncol 45(6):243-248, 2022. e-Pub 2022. PMID: 35485607.
18. Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer. e-Pub 2022. PMID: 35680139.
19. Diao K, Lombe DC, Mwaba CK, Wu J, Kizub DA, Cameron CA, Chiao EY, Msadabwe SC, Lin LL. Building Capacity for Cancer Research in the Era of COVID-19: Implementation and Results From an International Virtual Clinical Research Training Program in Zambia. JCO Glob Oncol 8:e2100372, 2022. PMID: 35594499.
20. Saris DH, Smith AJB, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM. Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study. Gynecol Oncol Rep 40:100922, 2022. e-Pub 2022. PMID: 35242979.
21. Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2021. PMID: 34974906.
22. Surasi, Devaki Shilpa Sudha MD, Lin, Lilie MD, Ravizzini, Gregory MD, Wong, Franklin MD. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT. Clinical Nuclear Medicine 47(2):195-196, 2022.
23. Cory L, Brensinger C, Burger RA, Giuntoli RL, Morgan MA, Latif N, Lin LL, Ko EM. Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma. Gynecol Oncol Rep 39:100930, 2022. e-Pub 2022. PMID: 35111895.
24. Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
25. Young AJ, Pantel AR, Viswanath V, Dominguez TL, Makvandi M, Lee H, Li S, Schubert EK, Pryma DA, Farwell MD, Mach RH, Simpkins F, Lin LL, Mankoff DA, Doot RK. Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer. J Nucl Med 63(1):44-50, 2022. e-Pub 2021. PMID: 33863820.
26. Lakomy DS, Wu J, Chapman BV, Yu ZH, Lee B, Klopp AH, Jhingran A, Eifel PJ, Lin LL. Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer. Pract Radiat Oncol 12(3):e207-e215, 2022. e-Pub 2021. PMID: 34958984.
27. Lee HS, Schwarz SW, Schubert EK, Chen DL, Doot RK, Makvandi M, Lin LL, McDonald ES, Mankoff DA, Mach RH. The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1. Radiol Imaging Cancer 4(1):e210070, 2022. PMID: 35089089.
28. Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, Castillo P, Hughes N, Mohammedsaid M, Jhingran A, Klopp AH, Choi S, Fuller CD, Lin LL. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation. Pract Radiat Oncol 12(4):e296-e305, 2022. e-Pub 2022. PMID: 35278717.
29. Huang A, Gunther JR, Lin LL. Analyzing the Role of Research in the Radiation Oncology Match. Adv Radiat Oncol 7(3):100891, 2022. e-Pub 2022. PMID: 35243182.
30. Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
31. Huang A, Gunther JR, Lin LL. In Reply to Sindhu et al. Adv Radiat Oncol 7(6):101067, 2022. e-Pub 2022. PMID: 36420206.
32. MacDuffie E, Bvochora-Nsingo M, Chiyapo S, Balang D, Chambers A, George JM, Tuli S, Lin LL, Zetola NM, Ramogola-Masire D, Grover S. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana. Infect Agent Cancer 16(1):55, 2021. e-Pub 2021. PMID: 34344430.
33. Garcia-Soto AE, McKenzie ND, Whicker ME, Pearson JM, Jimenez EA, Portelance L, Hu JJ, Lucci JA, Qureshi R, Kossenkov A, Schwartz L, Mills GB, Maity A, Lin LL, Simpkins F. Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer. Cancer 127(13):2279-2293, 2021. e-Pub 2021. PMID: 33932031.
34. Sezen D, Patel RR, Tang C, Onstad M, Nagarajan P, Patel SP, Welsh JW, Lin LL. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma. Gynecol Oncol 161(3):645-652, 2021. e-Pub 2021. PMID: 33795130.
35. Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
36. El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
37. Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. Gynecol Oncol 159(3):607-610, 2020. e-Pub 2020. PMID: 32972783.
38. Ko EM, Brensinger CM, Cory L, Giuntoli RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. Gynecol Oncol 159(2):394-401, 2020. e-Pub 2020. PMID: 32800655.
39. Lin LL, Lakomy DS, Chiao EY, Strother RM, Wirth M, Cesarman E, Borok M, Busakhala N, Chibwesha CJ, Chinula L, Ndlovu N, Orem J, Phipps W, Sewram V, Vogt SL, Sparano JA, Mitsuyasu RT, Krown SE, Gopal S. Clinical Trials for Treatment and Prevention of HIV-associated Malignancies in sub-Saharan Africa: Building Capacity and Overcoming Barriers. JCO Glob Oncol 6:1134-1146, 2020. PMID: 32697667.
40. Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin LL, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
41. Lin LL, Lakomy DS, Ning MS, Simpkins F, Jhingran A. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Int J Gynecol Cancer 30(4):409-423, 2020. e-Pub 2020. PMID: 32193219.
42. Lakomy DS, Urbauer DL, Westin SN, Lin LL. Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers. Clin Transl Radiat Oncol 21:56-61, 2020. e-Pub 2019. PMID: 31993510.
43. Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy 19(4):427-437, 2020. e-Pub 2019. PMID: 31786169.
44. Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
45. Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 10(4):220-234, 2020. e-Pub 2020. PMID: 32473857.
46. Rengan R, Mick R, Pryma DA, Lin LL, Christodouleas J, Plastaras JP, Simone CB, Gupta AK, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Lam S, Patsch D, Hahn SM, Maity A. Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial. JAMA Oncol 5(10):1464-1472, 2019. e-Pub 2019. PMID: 31436839.
47. Singer L, Damast S, Lin L, Taunk N, Lee LJ, Albuquerque K, Chino J, Petereit D, Joyner M, Fields E. Development of a Multi-Institutional Simulation-Based Gynecologic Brachytherapy Curriculum. Int J Radiat Oncol Biol Phys 104(5):1175-1176, 2019. PMID: 31327414.
48. Vogel J, Wang X, Troxel AB, Simone CB, Rengan R, Lin LL. Prospective assessment of demographic characteristics associated with worse health related quality of life measures following definitive chemoradiation in patients with locally advanced non-small cell lung cancer. Transl Lung Cancer Res 8(4):332-339, 2019. PMID: 31555509.
49. Grover S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, Bhatia RK, Balang D, Chiyapo SP, Luckett R, Ramogola-Masire D, Dryden-Peterson SL, Lin LL, Shin SS, Zetola NM. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana. Cancer 125(10):1645-1653, 2019. e-Pub 2019. PMID: 30801696.
50. Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B. Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma. Int J Radiat Oncol Biol Phys 103(4):851-860, 2019. e-Pub 2018. PMID: 30445173.
51. Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol 14:40-46, 2019. e-Pub 2018. PMID: 30555940.
52. Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy 18(5):620-626, 2019. e-Pub 2019. PMID: 31160198.
53. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
54. Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis. Gynecol Oncol 151(3):573-578, 2018. e-Pub 2018. PMID: 30333082.
55. Maity A, Mick R, Huang AC, George SM, Farwell MD, Lukens JN, Berman AT, Mitchell TC, Bauml J, Schuchter LM, O'Hara M, Lin LL, Demichele A, Christodouleas JP, Haas NB, Patsch DM, Hahn SM, Minn AJ, Wherry EJ, Vonderheide RH. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br J Cancer 119(10):1200-1207, 2018. e-Pub 2018. PMID: 30318516.
56. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
57. Xanthopoulos EP, Grover S, Puri PM, Corradetti MN, Heilbroner SP, Mitra N, Simone CB, Lin LL. Survival benefit of Adjuvant radiation therapy in node-positive vulvar cancer. Am J Clin Oncol 41(9):845-850, 2018. PMID: 30134287.
58. Bi Y, Verginadis II, Dey S, Lin L, Guo L, Zheng Y, Koumenis C. Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas. Gynecol Oncol 150(3):534-544, 2018. e-Pub 2018. PMID: 30025822.
59. Yalamanchi P, Shabason JE, Zhang X, Ko EM, Lin LL. Use of Aggressive Surveillance for Locoregional Edometrial Cancer After Local Therapy. Int J Gynecol Cancer 28(7):1264-1270, 2018. PMID: 30036223.
60. Bender Ignacio RA, Lin LL, Rajdev L, Chiao E. Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials. J Natl Compr Canc Netw 16(8):1018-1026, 2018. PMID: 30099376.
61. Hanlon A, Small W, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, Wells J, Bruner DW. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study. Cancer Nurs 41(3):200-209, 2018. e-Pub 2017. PMID: 28437283.
62. Makvandi M, Pantel A, Schwartz L, Schubert E, Xu K, Hsieh CJ, Hou C, Kim H, Weng CC, Winters H, Doot R, Farwell MD, Pryma DA, Greenberg RA, Mankoff DA, Simpkins F, Mach RH, Lin LL. Evaluating PARP-1 with PET imaging in ovarian cancer. J Clin Invest 128(97992):2116-2126, 2018. e-Pub 2018. PMID: 29509546.
63. Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, Gwangwava E, Tsietso S, Kayembe MKA, Ramogola-Masire D, Dryden-Peterson S, Mahantshetty U, Viswanathan AN, Zetola NM, Lin LL. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Int J Radiat Oncol Biol Phys 101(1):201-210, 2018. e-Pub 2018. PMID: 29619965.
64. Guttmann DM, Gabriel P, Kennedy C, Rate W, Grizos W, Nagda S, Wojtowicz L, Lin , Freedman GM. Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whold breast. Breast J 24(2):128-132, 2018. e-Pub 2017. PMID: 28703444.
65. Xu MJ, Maity A, Vogel J, Kirk M, Zhai H, Both S, Lin LL. Proton Therapy Reduces Normal Tissue Dose in Extended Field Pelvic Radiation for Endometrial Cancer. Int J Part Ther 4(3):1-11, 2018. e-Pub 2018. PMID: 31773009.
66. Garcia RM, Hanlon A, Small W, Strauss JB, Lin L, Wells J, Bruner DW. The relationship between Body Mass Index and Sexual Function in Endometrial Cancer. Oncol Nurs Forum 45(1):25-32, 2018. PMID: 29251291.
67. Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol 40(6):598-604, 2017. PMID: 26237194.
68. Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy. e-Pub 2017. PMID: 28888417.
69. Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM. Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?. Radiother Oncol 124(2):204-207, 2017. e-Pub 2017. PMID: 28733055.
70. Sander Effron S, Makvandi M, Lin LL, Xu K, Li S, Lee H, Hou C, Pryma DA, Koch C, Mach RH. PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy. Cancer Biother Radiopharm 32(1):9-15, 2017. e-Pub 2017. PMID: 28118040.
71. Fields EC, McGuire WP, Lin LL, Temkin SM. Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future. Front Oncol 7:177, 2017. e-Pub 2017. PMID: 28871275.
72. Taku N, Dise J, Kenton O, Yin L, Teo BK, Lin LL. Quantification of vaginal motion associated with daily endorectal balloon placement during whole pelvis radiotherapy for gynecologic cancers. Radiother Oncol 120(3):532-536, 2016. e-Pub 2016. PMID: 27247058.
73. Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D, Kebabonye-Pusoentsi M, Clayman R, Mapes AC, Tapela N, Asmelash A, Medhin H, Viswanathan AN, Russell AH, Lin LL, Kayembe MK, Mmalane M, Randall TC, Chabner B, Lockman S. HIV Infection and Survival Among Women With Cervical Cancer. J Clin Oncol. e-Pub 2016. PMID: 27573661.
74. Dean LT, Zhang X, Latif N, Giuntoli R, Lin LL, Haggerty A, Kim S, Shalowitz D, Stashwick C, Simpkins F, Burger R, Morgan M, Ko E, Schmitz K. Race-based disparities in loss of functional independence after hysterectomy for uterine cancer. Support Care Cancer 24(8):3573-80, 2016. e-Pub 2016. PMID: 27025595.
75. Xu MJ, Kirk M, Zhai H, Lin LL. Bag and loop small bowel contouring strategies differentially estimate small bowel dose for post-hysterectomy women receiving pencil beam scanning proton therapy. Acta Oncol 55(7):900-8, 2016. e-Pub 2016. PMID: 26927612.
76. Lin LL, Kirk M, Scholey J, Taku N, Kiely JB, White B, Both S. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer. Int J Radiat Oncol Biol Phys 95(1):181-9, 2016. e-Pub 2015. PMID: 26372435.
77. Yan C, Fischer JP, Freedman GM, Basta MN, Kovach SJ, Serletti JM, Lin LL, Wu LC. The Timing of Breast Irradiation in Two-Stage Expander/Implant Breast Reconstruction. Breast J 22(3):322-9, 2016. e-Pub 2016. PMID: 26864463.
78. Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women with Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Int J Gynecol Cancer 26(1):141-8, 2016. PMID: 26509850.
79. Zetola N, Grover S, Modongo C, Chiyapo S, Nsingo-Bvochara M, Narasimhamurthy M, Lin LL, Jarvis J, Shin S, Robertson E. Collision of Three Pandemics: The Coexistence of Cervical Cancer, HIV Infection, and Prior Tuberculosis in the Sub-Saharan Country of Botswana. J Glob Oncol 2(1):47-50, 2016. PMID: 28717682.
80. Li YR, Kirk M, Lin LL. Proton Therapy for Vaginal Reirradiation. Int J Part Ther 3(2):320-326, 2016. e-Pub 2016. PMID: 28989947.
81. Zhang X, Haggerty AF, Brown JC, Giuntoli R, Lin LL, Simpkins F, Dean LT, Ko E, Morgan MA, Schmitz KH. The prescription or proscription of exercise in endometrial cancer care. Gynecol Oncol 139(1):155-9, 2015. e-Pub 2015. PMID: 26307400.
82. Dise J, Liang X, Scheuermann J, Anamalayil S, Mesina C, Lin LL, Teo BK. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy. Brachytherapy 14(5):619-25, 2015. e-Pub 2015. PMID: 26073225.
83. Xanthopoulos EP, Handorf E, Simone CB, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. Pract Radiat Oncol 5(4):e355-63, 2015. e-Pub 2015. PMID: 25649540.
84. Lin LL, Vennarini S, Dimofte A, Ravanelli D, Shillington K, Batra S, Tochner Z, Both S, Freedman G. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer. Acta Oncol 54(7):1032-9, 2015. e-Pub 2015. PMID: 25789715.
85. Teo BK, Bonner Millar LP, Ding X, Lin LL. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation. Radiother Oncol 115(2):195-202, 2015. e-Pub 2015. PMID: 26002306.
86. White BM, Vennarini S, Lin LL, Freedman G, Santhanam A, Low DA, Both S. Accuracy of routine treatment planning 4-dimensional and deep-inspiration breath-hold computed tomography delineation of the left anterior descending artery in radiation therapy. Int J Radiat Oncol Biol Phys 91(4):825-31, 2015. PMID: 25752397.
87. Fang P, Tan KS, Grover S, McFadien MK, Troxel AB, Lin LL. Psychosocial encounters correlates with higher patient-reported functional quality of life in gynecological cancer patients receiving radiotherapy. Radiat Oncol 10:34, 2015. e-Pub 2015. PMID: 25657054.
88. Grover S, Raesima M, Bvochora-Nsingo M, Chiyapo SP, Balang D, Tapela N, Balogun O, Kayembe MK, Russell AH, Monare B, Tanyala S, Bhat J, Thipe K, Nchunga M, Mayisela S, Kizito B, Ho-Foster A, Gaolebale BE, Gaolebale PA, Efstathiou JA, Dryden-Peterson S, Zetola N, Hahn SM, Robertson ES, Lin LL, Morroni C, Ramogola-Masire D. Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs. Front Oncol 5:239, 2015. e-Pub 2015. PMID: 26579491.
89. Brown JC, Lin LL, Segal S, Chu CS, Haggerty AE, Ko EM, Schmitz KH. Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivors. Support Care Cancer 22(11):3017-25, 2014. e-Pub 2014. PMID: 24906839.
90. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 90(2):320-8, 2014. PMID: 25304792.
91. Lin LL, Brown JC, Segal S, Schmitz KH. Quality of life, body mass index, and physical activity among uterine cancer patients. Int J Gynecol Cancer 24(6):1027-32, 2014. PMID: 24927246.
92. Latif NA, Haggerty A, Jean S, Lin LL, Ko E. Adjuvant therapy in early-stage endometrial cancer: a systematic review of the evidence, guidelines, and clinical practice in the U.S. Oncologist 19(6):645-53, 2014. e-Pub 2014. PMID: 24821823.
93. Lin LL, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R, Kennedy AR. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett 7(4):1151-1158, 2014. e-Pub 2014. PMID: 24944684.
94. Grover S, Xu MJ, Yeager A, Rosman L, Groen RS, Chackungal S, Rodin D, Mangaali M, Nurkic S, Fernandes A, Lin LL, Thomas G, Tergas AI. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol 4:380, 2014. e-Pub 2015. PMID: 25657930.
95. Li H, Tennapel MJ, Ahmed A, Lin LL, Bhatia S, Jacobson G. Uterine carcinosarcoma confined to the pelvis:A retrospective review and outcome analysis. Journal of Radiotherapy, 2014.
96. Welliver MX, Lin LL. Evaluation of a balloon-based vaginal packing system and patient controlled analgesia for patients with cervical cancer undergoing high dose rate intracavitary brachytherapy. Practical Radiation Oncology 3(4):263-268, 2013.
97. Fang P, Tan KS, Troxel AB, Rengan R, Freedman G, Lin LL. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy. Breast Cancer Res Treat 141(1):125-33, 2013. e-Pub 2013. PMID: 23942874.
98. Xanthopoulos EP, Corradetti MN, Mitra N, Fernandes AT, Kim M, Grover S, Christodouleas JP, Evans TL, Stevenson JP, Langer CJ, Lee TT, Pryma DA, Lin LL, Simone CB, Apisarnthanarax S, Rengan R. Impact of PET staging in limited-stage small-cell lung cancer. J Thorac Oncol 8(7):899-905, 2013. PMID: 23608814.
99. Rey F, Chang C, Mesina C, Dixit N, Kevin Teo BK, Lin LL. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer. Radiother Oncol 107(1):112-6, 2013. e-Pub 2013. PMID: 23333023.
100. Showalter SL, Grover S, Sharma S, Lin LL, Czerniecki BJ. Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis. Ann Surg Oncol 20(4):1287-94, 2013. e-Pub 2012. PMID: 23135311.
101. Grover S, Showalter S, Kraft KH, Suneja G, Lin LL. The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer. International Journal of Gynecological Cancer: official journal of the International Gynecological Cancer Society 23(3):494-9, 2013.
102. Bahng AY, Chu C, Wileyto P, Rubin S, Lin LL. Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma. J Gynecol Oncol 23(4):257-64, 2012. e-Pub 2012. PMID: 23094129.
103. Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, Koch CJ, Minn H. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm 27(7):412-9, 2012. e-Pub 2012. PMID: 22897720.
104. Lin LL, Hertan L, Rengan R, Teo BK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys 83(2):670-5, 2012. e-Pub 2011. PMID: 22208974.
105. Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin LL, Rengan R. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 83(1):340-7, 2012. e-Pub 2011. PMID: 22104359.
106. Rengan R, Mick R, Pryma D, Rosen MA, Lin LL, Maity AM, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Prendergast S, Sharkoski T, Hahn SM. A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol 7(4):709-15, 2012. PMID: 22425919.
107. Milby Berman A, Both S, Ingram M, Lin LL. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. Int J Radiat Oncol Biol Phys 82(3):e477-84, 2012.
108. Bahng AY, Dagan A, Bruner DW, Lin LL. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 82(2):667-73, 2012. e-Pub 2011. PMID: 21300451.
109. Liao JB, Jean S, Wilkinson-Ryan I, Ford AE, Tanyi JL, Hagemann AR, Lin LL, McGrath CM, Rubin SC. Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 120(1):108-12, 2011. PMID: 20937524.
110. Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, Langer C, Lin LL, Hahn S, Glatstein E, Rengan R. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Radiother Oncol 95(2):178-84, 2010. e-Pub 2010. PMID: 20356642.
111. Hill-Kayser CE, Avery S, Mesina CF, James P, Friedberg JS, Cengel K, Lin LL, Hahn SM, Rengan R. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques. J Thorac Oncol 4(11):1431-7, 2009. PMID: 19745767.
112. Lin LL, Hahn SM. Combined modality therapy in the elderly population. Curr Treat Options Oncol 10(3-4):195-204, 2009. e-Pub 2009. PMID: 19507038.
113. Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW. .: (18)-F-Fluorodeoxyglucose positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 72(5):1502-7, 2008.
114. Nemani D, Mitra N, Guo M, Lin LL. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 111(1):82-8, 2008. PMID: 18674808.
115. Macdonald DM, Lin LL, Biehl K, Mutic S, Nantz R, Grigsby PW. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 71(2):618-24, 2008. e-Pub 2008. PMID: 18407429.
116. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126-30, 2008. PMID: 18352781.
117. Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 106(1):215-20, 2007. e-Pub 2007. PMID: 17482665.
118. Lin LL, Mutic S, Low DA, LaForest R, Vicic M, Zoberi I, Miller TR, Grigsby PW. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys 67(1):91-6, 2007. PMID: 17189066.
119. Lin LL, Yang Z, Mutic S, Miller TR, Grigsby PW. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 65(1):177-81, 2006. e-Pub 2006. PMID: 16545921.
120. Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 101(1):147-51, 2006. e-Pub 2005. PMID: 16263155.
121. Lin LL, Mutic S, Malyapa RS, Low DA, Miller TR, Vicic M, Laforest R, Zoberi I, Grigsby PW. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 63(5):1494-501, 2005. e-Pub 2005. PMID: 16154713.
122. Lin LL, Grigsby PW, Powell MA, Mutch DG. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 63(2):500-4, 2005. PMID: 16168841.
123. Lin LL, Myerson RJ, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Picus J. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. American Journal of Clinical Oncology 23(3):234-41, 2005.
124. Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21(41):6317-27, 2002. PMID: 12214272.
125. Beckman DL, Lin LL, Quinones ME, Longmore GD. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Blood 94(8):2667-75, 1999. PMID: 10515870.

Abstracts

1. Fang P, Tan K, Grover S, Troxel A, Lin, L. Psychological and social work encounters predict higher patient-reported functional quality of life in gynecological cancer treatment. Int J Radiat Oncol Biol Phys 87(Supplement 2):S75, 2013.
2. Barlow CM, Pellinat M, Armstrong D, Da Costa A, Halsel D, Malamet C, Hahn, SM, Prendergast S, Lin L. Creation of a secure HIPAA-compliant bioinformatics system to support a bi-institutional biomarker discovery and correlative quality of life study. Int J Radiat Oncol Biol Phys 75(3):S138-S139, 2009.

Book Chapters

1. Feddock, J., Kunos, C., Pompos, A., Albuquerque, K.,Lin, LL.. Chapter 8: Stereotactic ablative radiotherapy and other newer treatment delivery techniques for gynecologic cancers. In: Radiation Therapy Techniques for Gynecological Cancers, 2018.
2. Bvochara M, Grover S, Gierga DP, Makufa R, Efstathiou JA, Dixit N, Clayman RH, Russell AH, Lin LL, Kasese J. Cervical brachytherapy exchange: steps towards oncology capacity building in Botswana. In: The Oncologist, e1-2, 2014.
3. Lin LL. Commentary: Long-term survival outcomes following internal mammary node irradiation in Stage II-III breast cancer: results of a large retrospective study with 12 year follow-up. In: Breast Diseases: A Yearbook Quarterly, 76-77, 2014.
4. Lin LL, Freedman G. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. In: series with long-term follow-up, 97-98, 2013.
5. Lin LL. IMRT for gynecologic cancers. In: Practical Essentials of Intensity Modulated Radiation Therapy. Lippincott Williams & Wilkins, 2013.
6. Bonner Millar L, Lin LL. Radiation therapy for gynecologic malignancies. In: Manual of Gynecologic Oncology. World Scientifi, 2011.
7. Hristov B, Lin LL. Vaginal Cancer. In: Radiation oncology: A question based review, 2011.
8. Tuli R, Lin LL. Ovarian Cancer. In: Radiation oncology: A question based review, 2011.
9. Zeng J, Lin LL. Cervical Cancer. In: Radiation Oncology: A Question Based Review, 2011.
10. Lin LL and Grigsby PW. Cervical cancer: Positron emission tomography and positron emission tomography/computed tomography. In: Methods of Cancer Diagnosis, Therapy and Prognosis. Springer, 2010.
11. Chu C, Lin LL, Rubin S. Cancer of the uterine body. In: Cancer: Principles and Practice of Oncology. 8th. Raven, 2008.
12. Lin LL, Dehdashti F, Siegel B, Grigsby PW. PET and PET/CT of tumors of the female genital tract. In: Clinical Molecular Anatomic Imaging: PET, PET/CT, and SPECT/CT Integrated Modality Imaging. 2nd. Lippincott Williams and Wilkins, 427-442, 2007.

Books (edited and written)

1. Levine DA, Gaillard S, Lin LL, Chi DS, Berchuck A, Dizon DS, Yashar CM. Handbook for Principals and Practice of Gynecologic Oncology. 3rd Edition. Wolters Kluwer, 2020.